Balloon trick during cancer surgery may prevent stomach troubles
NCT ID NCT07355374
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether inflating a small balloon in the pylorus (the valve between stomach and small intestine) during minimally invasive esophageal cancer surgery can prevent delayed stomach emptying, a common complication. About 116 patients will be randomly assigned to receive the balloon dilation or standard surgery alone. The main goal is to see if the procedure reduces stomach emptying problems within the first two weeks after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- endoscopic pylorus balloon dilation
- What this could lead to
- If effective, this simple procedure could become a standard addition to esophagectomy, reducing complications and speeding recovery.
- What could go wrong
- This is a single-center trial with 116 patients, so results may not apply broadly. The procedure also carries rare risks like perforation or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELAYED GASTRIC CONDUIT EMTPYING (DGCE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clarunis University Digestive Health Care Center Basel
RECRUITINGBasel, Canton of Basel-City, 4058, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Target antibody shrink Hard-to-Treat cancers?
- New PET tracer could spot cancers that standard scans overlook
- Rare cancer study: does surgery help patients live longer?
- Massive study sheds light on esophageal cancer surgery outcomes
- New hope for advanced cancer patients as experimental drug enters human testing.
- When to treat? new trial aims to optimize therapy for oligometastatic esophageal and gastric cancer